Á lódáil...
Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment. Of 692 patients who received mesalazine for IBD between 2014 and March 2...
Na minha lista:
| Foilsithe in: | Sci Rep |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Nature Publishing Group UK
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747557/ https://ncbi.nlm.nih.gov/pubmed/33335169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79207-z |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|